Results 131 to 140 of about 2,319 (150)

The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma Patients

open access: yesJournal of Personalized Medicine, 2022
We evaluated switching from brinzolamide 1% or brimonidine 0.1% to a fixed-combination of brinzolamide 1% and brimonidine 0.1%, and then determined the efficacy, safety, and satisfaction associated with these changes in glaucoma patients.
Yoshiaki Kiuchi   +2 more
exaly   +2 more sources

The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients

open access: yesJournal of Clinical Medicine, 2021
We evaluated glaucoma patients for the efficacy, safety and satisfaction associated with switching from brinzolamide 1% and brimonidine 0.1% to a fixed combination of brinzolamide 1% and brimonidine 0.1%. A total of 22 glaucoma patients were enrolled and
Hideaki Okumichi   +2 more
exaly   +2 more sources

Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study

open access: yesJournal of Clinical Medicine, 2023
Purpose: To evaluate the concentrations of brimonidine and brinzolamide in the vitreous and aqueous humor after instillation of a 0.1% brimonidine tartrate and 1% brinzolamide fixed-combination ophthalmic suspension.
Yutaka Yamada   +2 more
exaly   +2 more sources

Direct and crossover effects of brinzolamide, betaxolol, and latanoprost on choroidal thickness

open access: yesCutaneous and Ocular Toxicology, 2019
Aslan, Mehmet Gokhan/0000-0002-3250-1606; Findik, Huseyin/0000-0001-7343-8757Purpose: To investigate the acute effects of brinzolamide, betaxolol, and latanoprost (drugs commonly used in the medical management of glaucoma) on choroidal thickness using ...
Huseyin Fındık   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Mini-Review on Bioanalytical Estimation of Brinzolamide

Current Pharmaceutical Analysis, 2022
Sankha Bhattacharya
exaly  

Periocular allergic contact dermatitis caused by brinzolamide

Contact Dermatitis, 2021
Ruiz-Villaverde R   +1 more
exaly  

Brinzolamide

Expert Opinion on Pharmacotherapy, 2008
Michele Iester
exaly  

Home - About - Disclaimer - Privacy